The HCPLive Rheumatology condition center page is a comprehensive resource for clinical news and insights on rheumatologic disease. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for arthritis, gout, nr-AxSpA, and more.
May 1st 2024
FDA approves label update for voclosporin (Lupkynis) in lupus nephritis, reflecting long-term AURORA data and new kidney function monitoring guidance.
"REEL" Time Patient Counseling™: Integrating Biosimilars into the Clinical Conversation
View More
Cases and Conversations™: Keeping Up with Novel Approaches to Managing ANCA-Associated Vasculitis
November 2024
Register Now!
EGPA: Highlighting the Patient Journey to Improve the Differential Diagnosis and Accelerate the Initiation of Guideline-Based Care
View More
Expert Illustrations & Commentaries™: Envisioning Novel Therapeutic Approaches to Managing ANCA-associated Vasculitis
View More
Clinical Consultations™: Optimal Approaches to Recognizing and Treating ANCA-Associated Vasculitis
View More
Early Diagnosis and Treatment of Lupus Essential in Racial/Ethnic Populations
June 4th 2019A study published last month in Arthritis Care & Research shows that racial/ethnic minorities disproportionately have more severe cases of systemic lupus erythematosus (SLE). In this slideshow, we summarize the findings, but we'd like to know what you think. Email us your comments at areyes@mmhgroup.com.
Despite Warnings, Opioid Prescriptions Still Widespread in Osteoarthritis
June 3rd 2019Despite recommendations against using opioids and benzodiazepines to treat osteoarthritis pain, new research shows significant numbers of patients, especially older patients, are still receiving prescriptions for these medications.
ACR Updates Juvenile Arthritis Treatment Recommendations
May 31st 2019The American College of Rheumatology and the Arthritis Foundation have updated the 2013 treatment guidelines for juvenile idiopathic arthritis (JIA), which includes juvenile non-systemic polyarthritis, sacroiliitis, and enthesitis. In this slideshow, we highlight the recommendations.
FDA Rheumatology Drug Approvals: Pediatric lupus, spondyloarthritis and more
May 23rd 2019From a new biosimilar to a first-ever approved drug to treat pediatric lupus patients, the Food & Drug Administration has approved several new medications in recent months. In this slideshow, we offer a brief overview of these new therapeutics.
Contribute to Rheumatology Network
May 22nd 2019Welcome to Rheumatology Network, an online publication of the ModernMedicine Network for healthcare professionals. What's inside? Research news summaries, conference coverage, case studies, photo clinics and more. We welcome contributing articles from physicians, nurses and other healthcare professionals.
PsA Quiz: Can you identify the appropriate treatment for newly diagnosed patients?
May 21st 2019In round two of our ongoing psoriatic arthritis quiz series, we focus on treatment recommendations made in the 2018 ACR/NPF psoriatic arthritis treatment guidelines. We also include a puzzler based on findings from a newly published study.
Remission in Axial Spondyloarthritis Unlikely without Biologics
May 16th 2019Remission is unlikely in non-radiographic axial spondyloarthritis without biologic therapy. Adding certolizumab to background therapy can lead to significant improvements in disease activity compared to placebo, researchers find.
Managing Rheumatic Medications after Hip or Knee Surgery
May 16th 2019To help clinicians manage antirheumatic drug therapy, the ACR and the American Association of Hip and Knee Surgeons developed evidence-based guidelines for the perioperative management of antirheumatic medication for patients with rheumatic diseases undergoing knee or hip surgery. In this slideshow, we outline those recommendations.
Expert Q&A: How a lupus self-management program is turning lives around
May 14th 2019African American women are disproportionately likely to develop systemic lupus erythematosus, and their disease course is more severe than other demographic groups, says Dr. Edith Williams. In this Q&A, she introduces us to a peer-mentoring program designed to foster self-management.
Patient Stories Capture the Immeasurable
May 14th 2019Patient-doctor narrative matters, says Lisa Rosenbaum, M.D., a cardiologist with Brigham and Women's Hospital in Boston. She shared her insights on patient narratives last month at LUPUS 2019 in San Francisco where she gave the keynote address. Learn more in this Q&A.